References
- Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009;136:642-655 https://doi.org/10.1016/j.cell.2009.01.035
- Shenouda SK, Alahari SK. MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 2009; 28:369-378 https://doi.org/10.1007/s10555-009-9188-5
- Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008;133:217-222 https://doi.org/10.1016/j.cell.2008.04.001
- Thorgeirsson SS, Lee JS, Grisham JW. Functional genomics of hepatocellular carcinoma. Hepatology 2006;43(2 suppl 1): S145-S150
- Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology 2008;48:2047-2063 https://doi.org/10.1002/hep.22580
- Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008;47:1955-1963 https://doi.org/10.1002/hep.22256
- Varnholt H, Drebber U, Schulze F, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008;47:1223-1232 https://doi.org/10.1002/hep.22158
- Ji J, Shi J, Budhu A, et al. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009;361:1437-1447 https://doi.org/10.1056/NEJMoa0901282
- Boix L, Bruix J. MicroRNA analysis for outcome prediction in hepatitis B virus-related liver cancer. Gastroenterology 2010;138:1624-1626 https://doi.org/10.1053/j.gastro.2010.02.021
- Breitenstein S, Dimitroulis D, Petrowsky H, Puhan MA, Mullhaupt B, Clavien PA. Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis. Br J Surg 2009;96:975-981 https://doi.org/10.1002/bjs.6731
- Zhang CH, Xu GL, Jia WD, Ge YS. Effects of interferon alpha treatment on recurrence and survival after complete resection or ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Int J Cancer 2009;124:2982-2988 https://doi.org/10.1002/ijc.24311
- Sun HC, Tang ZY, Wang L, et al. Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. J Cancer Res Clin Oncol 2006;132:458-465 https://doi.org/10.1007/s00432-006-0091-y
- Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007;317:121-124 https://doi.org/10.1126/science.1140485
- Kota J, Chivukula RR, O'Donnell KA, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009;137:1005-1017 https://doi.org/10.1016/j.cell.2009.04.021